FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Neurolief’s Digital Migraine Treatment Earns CE Mark

July 10, 2019
A A

Neurolief has received the CE Mark for Relivion, an over-the-counter, non-invasive neuromodulation digital treatment for migraines.

The adaptive, multi-channel technology uses an adjustable headset that gives off precise modulated pulses to six branches of nerves in the head to alleviate migraines.

The device, which avoids the risks and costs of surgery and the side effects of medications, connects to a mobile app and learns to deliver personalized treatments over time.

View today's stories